IBM vastly improves delivery of nanomeds that kill bacteria where antibiotics fail
Editor's Pick Are you ready for the era of the nanomeds? These tiny synthetic molecules can tear bacteria cells apart.
Editor's Pick Are you ready for the era of the nanomeds? These tiny synthetic molecules can tear bacteria cells apart.
Neosil, an Emeryville, Calif., company focused on dermatology products, raised a $10 million in venture debt from Hercules Technology Growth Capital. The debt funding follows the company’s $32 million first-round venture financing in 2004, which involved MPM Capital and Burrill …